Valbiotis SA (EPA:ALVAL)
1.070
-0.022 (-2.01%)
Apr 2, 2026, 5:35 PM CET
Valbiotis Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8.68 | 11.58 | 25.02 | 20.83 | 21.82 |
Cash & Short-Term Investments | 8.68 | 11.58 | 25.02 | 20.83 | 21.82 |
Cash Growth | -25.08% | -53.71% | 20.11% | -4.54% | 49.60% |
Accounts Receivable | 0.08 | 0.1 | 0.29 | 0.24 | 0.08 |
Other Receivables | 0.54 | 2.86 | 3.95 | 2.54 | 2.73 |
Receivables | 0.62 | 2.96 | 4.24 | 2.78 | 2.81 |
Inventory | 2.47 | 2.09 | 1.01 | 0.53 | 0.42 |
Prepaid Expenses | 0.16 | 0.25 | 0.38 | - | - |
Other Current Assets | -0 | - | - | 0.16 | 0.15 |
Total Current Assets | 11.92 | 16.87 | 30.65 | 24.3 | 25.19 |
Property, Plant & Equipment | 1.18 | 1.47 | 1.41 | 1.82 | 2.22 |
Long-Term Investments | 0.09 | 0.16 | 0.17 | 0.15 | - |
Other Intangible Assets | 1.2 | 1.11 | 1.08 | 0.94 | 0.96 |
Long-Term Deferred Tax Assets | - | - | 0 | 0 | - |
Other Long-Term Assets | - | - | - | 0 | 0.17 |
Total Assets | 14.39 | 19.61 | 33.31 | 27.22 | 28.54 |
Accounts Payable | 0.75 | 1.5 | 1.87 | 1.57 | 1.46 |
Accrued Expenses | 1.46 | 1.87 | 1.29 | 1.09 | 0.73 |
Current Portion of Long-Term Debt | 1.73 | 1.63 | 1.61 | 1.14 | 1.03 |
Current Portion of Leases | 0.25 | 0.55 | 0.5 | 0.45 | 0.43 |
Current Unearned Revenue | - | 0 | 3.51 | 3.86 | 4.29 |
Other Current Liabilities | - | - | 0 | - | - |
Total Current Liabilities | 4.18 | 5.55 | 8.77 | 8.11 | 7.94 |
Long-Term Debt | 2.21 | 2.52 | 3.9 | 4.35 | 4.6 |
Long-Term Leases | 0.91 | 1.02 | 0.88 | 1.23 | 1.53 |
Pension & Post-Retirement Benefits | 0.13 | 0.15 | 0.16 | 0.14 | 0.14 |
Other Long-Term Liabilities | - | - | - | 0.02 | 0.04 |
Total Liabilities | 7.43 | 9.24 | 13.71 | 13.86 | 14.25 |
Common Stock | 2.37 | 1.58 | 1.58 | 1.24 | 0.97 |
Additional Paid-In Capital | 6.16 | 1.25 | 18.23 | 37.1 | 32.33 |
Retained Earnings | -9.42 | -10.03 | -7.37 | -12.31 | -8.68 |
Comprehensive Income & Other | 7.85 | 17.56 | 7.16 | -12.67 | -10.33 |
Shareholders' Equity | 6.96 | 10.37 | 19.6 | 13.36 | 14.3 |
Total Liabilities & Equity | 14.39 | 19.61 | 33.31 | 27.22 | 28.54 |
Total Debt | 5.09 | 5.72 | 6.88 | 7.18 | 7.59 |
Net Cash (Debt) | 3.59 | 5.86 | 18.14 | 13.65 | 14.23 |
Net Cash Growth | -38.82% | -67.69% | 32.88% | -4.05% | 87.89% |
Net Cash Per Share | 0.18 | 0.37 | 1.46 | 1.35 | 1.55 |
Filing Date Shares Outstanding | 23.66 | 15.77 | 15.77 | 12.41 | 9.72 |
Total Common Shares Outstanding | 23.66 | 15.77 | 15.77 | 12.41 | 9.72 |
Working Capital | 7.73 | 11.33 | 21.88 | 16.19 | 17.26 |
Book Value Per Share | 0.29 | 0.66 | 1.24 | 1.08 | 1.47 |
Tangible Book Value | 5.76 | 9.26 | 18.52 | 12.41 | 13.34 |
Tangible Book Value Per Share | 0.24 | 0.59 | 1.17 | 1.00 | 1.37 |
Machinery | - | - | 0.79 | 0.78 | 0.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.